Welcome to LookChem.com Sign In|Join Free

CAS

  • or

515-94-6

Post Buying Request

515-94-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

515-94-6 Usage

Definition

ChEBI: A diamino acid that is alanine in which one of the hydrogens of the methyl group is replaced by an amino group.

Check Digit Verification of cas no

The CAS Registry Mumber 515-94-6 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,1 and 5 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 515-94:
(5*5)+(4*1)+(3*5)+(2*9)+(1*4)=66
66 % 10 = 6
So 515-94-6 is a valid CAS Registry Number.
InChI:InChI=1/C3H8N2O2/c4-1-2(5)3(6)7/h2H,1,4-5H2,(H,6,7)

515-94-6Relevant articles and documents

Synthetic studies on an antitumor antibiotic, bleomycin. XII. Preparation of an L-2,3-diaminopropionic acid derivative as a synthetic intermediate

Otsuka,Kittaka,Iimori,Yamashita,Kobayashi,Ohno

, p. 509 - 514 (1985)

-

Unique polyhalogenated peptides from the marine sponge Ircinia sp.

Fernández, Rogelio,Bayu, Asep,Hadi, Tri Aryono,Bueno, Santiago,Pérez, Marta,Cuevas, Carmen,Putra, Masteria Yunovilsa

, (2020/08/28)

Two new bromopyrrole peptides, haloirciniamide A (1) and seribunamide A (2), have been isolated from an Indonesian marine sponge of the genus Ircinia collected in the Thousand Islands (Indonesia). The planar structure of both compounds was assigned on the basis of extensive 1D and 2D NMR spectroscopy and mass spectrometry. The absolute configuration of the amino acid residues in 1 and 2 was determined by the application of Marfey's method. Compound 1 is the first dibromopyrrole cyclopeptide having a chlorohistidine ring, while compound 2 is a rare peptide possessing a tribromopyrrole ring. Both compounds failed to show significant cytotoxicity against four human tumor cell lines, and neither compound was able to inhibit the enzyme topoisomerase I or impair the interaction between programmed cell death protein PD1 and its ligand, PDL1.

Immunomodulatory peptides

-

, (2014/12/12)

The invention relates to peptides derivatized with a hydrophilic polymer which, in some embodiments, bind to human FcRn and inhibit binding of the Fc portion of an IgG to an FcRn, thereby modulating serum IgG levels. The disclosed compositions and methods may be used in some embodiments, for example, in treating autoimmune diseases and inflammatory disorders. The invention also relates, in further embodiments, to methods of using and methods of making the peptides of the invention.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 515-94-6